One World Pharma Inc
One World Products, Inc. engages in the provision of renewable and sustainable materials. It processes rubber, cellulose, hemp, and a range of bio-feedstocks into composites for automotive, industrial, and food packaging. The company was founded in 2018 and is headquartered in Las Vegas, Nevada.
One World Pharma Inc (OWPC) - Total Assets
Latest total assets as of September 2025: $6.62 Million USD
Based on the latest financial reports, One World Pharma Inc (OWPC) holds total assets worth $6.62 Million USD as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
One World Pharma Inc - Total Assets Trend (2016–2024)
This chart illustrates how One World Pharma Inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
One World Pharma Inc - Asset Composition Analysis
Current Asset Composition (December 2024)
One World Pharma Inc's total assets of $6.62 Million consist of 100.0% current assets and 0.0% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 62.2% |
| Accounts Receivable | $114.00 | 0.2% |
| Inventory | $16.23K | 23.8% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2016–2024)
This chart illustrates how One World Pharma Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: One World Pharma Inc's current assets represent 100.0% of total assets in 2024, an increase from 0.0% in 2016.
- Cash Position: Cash and equivalents constituted 62.2% of total assets in 2024, up from 0.0% in 2016.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2016.
- Asset Diversification: The largest asset category is inventory at 23.8% of total assets.
One World Pharma Inc Competitors by Total Assets
Key competitors of One World Pharma Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF
|
USA | $67.26 Billion |
|
Kamada
NASDAQ:KMDA
|
USA | $378.79 Million |
|
Dongwha Pharm.Co.Ltd
KO:000020
|
Korea | ₩654.63 Billion |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
|
China | CN¥27.28 Billion |
|
Yuhan Corp.
KO:000100
|
Korea | ₩3.05 Trillion |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
|
China | CN¥4.97 Billion |
|
Kotra Industries Bhd
KLSE:0002
|
Malaysia | RM363.90 Million |
|
Yuyu Pharma Inc
KO:000227
|
Korea | ₩202.42 Billion |
One World Pharma Inc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - One World Pharma Inc generates 0.07x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - One World Pharma Inc is currently not profitable relative to its asset base.
One World Pharma Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.07 | 0.04 | 0.25 |
| Quick Ratio | 0.06 | 0.03 | 0.09 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-3.95 Million | $ -3.15 Million | $ -1.28 Million |
One World Pharma Inc - Advanced Valuation Insights
This section examines the relationship between One World Pharma Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 12.63 |
| Latest Market Cap to Assets Ratio | 14.77 |
| Asset Growth Rate (YoY) | -30.9% |
| Total Assets | $68.30K |
| Market Capitalization | $1.01 Million USD |
Valuation Analysis
Premium Asset Valuation: The market values One World Pharma Inc's assets at a significant premium ( 14.77x), suggesting investors see substantial growth potential or unique competitive advantages.
Significant Asset Reduction: One World Pharma Inc's assets decreased by 30.9% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for One World Pharma Inc (2016–2024)
The table below shows the annual total assets of One World Pharma Inc from 2016 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $68.30K | -30.93% |
| 2023-12-31 | $98.88K | -96.88% |
| 2022-12-31 | $3.17 Million | +9.11% |
| 2021-12-31 | $2.90 Million | +106.25% |
| 2020-12-31 | $1.41 Million | -23.80% |
| 2019-12-31 | $1.85 Million | +263418.40% |
| 2018-12-31 | $701.00 | -- |
| 2017-12-31 | $0.00 | -- |
| 2016-12-31 | $0.00 | -- |